NZ241463A - Treatment/diagnosis of tumours with a complex of certain metals with hydroxyethyl ethylenediamine triacetic acid - Google Patents
Treatment/diagnosis of tumours with a complex of certain metals with hydroxyethyl ethylenediamine triacetic acidInfo
- Publication number
- NZ241463A NZ241463A NZ241463A NZ24146392A NZ241463A NZ 241463 A NZ241463 A NZ 241463A NZ 241463 A NZ241463 A NZ 241463A NZ 24146392 A NZ24146392 A NZ 24146392A NZ 241463 A NZ241463 A NZ 241463A
- Authority
- NZ
- New Zealand
- Prior art keywords
- treatment
- tumours
- diagnosis
- complex
- triacetic acid
- Prior art date
Links
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002184 metal Substances 0.000 title abstract 2
- 229910052751 metal Inorganic materials 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 150000002739 metals Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010068771 Soft tissue neoplasm Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Electroluminescent Light Sources (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/648,663 US5308606A (en) | 1991-01-30 | 1991-01-30 | Method of treating and/or diagnosing soft tissue tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ241463A true NZ241463A (en) | 2000-01-28 |
Family
ID=24601702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ241463A NZ241463A (en) | 1991-01-30 | 1992-01-30 | Treatment/diagnosis of tumours with a complex of certain metals with hydroxyethyl ethylenediamine triacetic acid |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5308606A (enExample) |
| EP (1) | EP0499098B1 (enExample) |
| JP (1) | JPH05505629A (enExample) |
| KR (1) | KR100219965B1 (enExample) |
| AT (1) | ATE216266T1 (enExample) |
| AU (1) | AU650944B2 (enExample) |
| CA (1) | CA2060332A1 (enExample) |
| DE (1) | DE69232554T2 (enExample) |
| FI (1) | FI924363A7 (enExample) |
| IE (1) | IE920311A1 (enExample) |
| IL (1) | IL100800A (enExample) |
| MX (1) | MX9200413A (enExample) |
| NZ (1) | NZ241463A (enExample) |
| SG (1) | SG45366A1 (enExample) |
| TW (1) | TW205509B (enExample) |
| WO (1) | WO1992013571A1 (enExample) |
| ZA (1) | ZA92663B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739313A (en) | 1995-11-13 | 1998-04-14 | Regents Of The University Of Minnesota | Radionuclide labeling of vitamin B12 and coenzymes thereof |
| US6806363B1 (en) * | 1999-04-16 | 2004-10-19 | Mayo Foundation For Medical Education & Research | Cobalamin conjugates useful as antitumor agents |
| WO2001028592A1 (en) * | 1999-10-15 | 2001-04-26 | Mayo Foundation For Medical Education And Research | Cobalamin conjugates useful as imaging agents and as antitumor agents |
| US7591995B2 (en) * | 1999-10-15 | 2009-09-22 | Mayo Foundation For Medical Education And Research | Cobalamin conjugates useful as imaging and therapeutic agents |
| MXPA02003772A (es) | 1999-10-15 | 2005-04-28 | Mayo Foundation | Conjugados de cobalamina, utiles como agentes para obtencion de imagen y como agentes terapeuticos. |
| TWI228512B (en) * | 2000-10-25 | 2005-03-01 | Mayo Foundation | Transcobalamin binding conjugates useful for treating abnormal cellular proliferation |
| AU2002322275A1 (en) * | 2001-06-20 | 2003-01-08 | Mayo Foundation For Medical Education And Research | Adenosyl-cobalamin fortified compositions |
| US20060074034A1 (en) * | 2001-09-17 | 2006-04-06 | Collins Douglas A | Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof |
| EP1435973A4 (en) * | 2001-09-28 | 2007-05-02 | Mayo Foundation | SIMULTANEOUS ADMINISTRATION OF A TRANSPORT PROTEIN WITH CONJUGATED COBALAMINE FOR THE DISTRIBUTION OF MEDICINAL PRODUCTS |
| KR100440725B1 (ko) * | 2002-06-20 | 2004-07-15 | 주식회사 그린진 바이오텍 | 비생물성 스트레스에 대한 단자엽 식물의 내성을증가시키는 방법 |
| WO2007008232A2 (en) * | 2004-09-03 | 2007-01-18 | Board Of Regents, The University Of Texas System | Locoregional internal radionuclide ablation of abnormal tissues. |
| US7419654B2 (en) * | 2004-10-08 | 2008-09-02 | Mrinal K. Dewanjee | Charge neutral complexes of paramagnetic metals as intracellular magnetic resonance imaging contrast agents |
| BRPI0610419A2 (pt) * | 2005-05-17 | 2012-10-23 | Cargill Inc | lecitina granular, lisolecitina, processo para produzir lecitina granular, composição granular, processo para produzir uma composição de lecitina granular, produto, e, processos para produzir lisolecitina granular e para produzir uma composição de lisolecitina granular |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US421452A (en) * | 1890-02-18 | Island | ||
| US4898724A (en) * | 1984-06-04 | 1990-02-06 | The Dow Chemical Company | Organis amine phosphonic acid complexes for the treatment of calcific tumors |
| US4897254A (en) * | 1984-09-21 | 1990-01-30 | The Dow Chemical Company | Radioactive compositions for the treatment of calcific tumors |
| DE3577550D1 (de) * | 1984-09-21 | 1990-06-13 | Dow Chemical Co | Aminocarbonsaeurekomplexe zur behandlung von knochentumoren. |
| NZ222304A (en) * | 1987-05-18 | 1990-10-26 | Dow Chemical Co | Suppression of bone marrow using samarium-153, gadolinium-159 or holmium-166 complexes |
-
1991
- 1991-01-30 US US07/648,663 patent/US5308606A/en not_active Expired - Lifetime
-
1992
- 1992-01-29 IL IL10080092A patent/IL100800A/en not_active IP Right Cessation
- 1992-01-29 AU AU10543/92A patent/AU650944B2/en not_active Ceased
- 1992-01-30 MX MX9200413A patent/MX9200413A/es not_active IP Right Cessation
- 1992-01-30 WO PCT/US1992/000683 patent/WO1992013571A1/en not_active Ceased
- 1992-01-30 JP JP92506262A patent/JPH05505629A/ja not_active Ceased
- 1992-01-30 DE DE69232554T patent/DE69232554T2/de not_active Expired - Fee Related
- 1992-01-30 CA CA002060332A patent/CA2060332A1/en not_active Abandoned
- 1992-01-30 ZA ZA92663A patent/ZA92663B/xx unknown
- 1992-01-30 AT AT92101569T patent/ATE216266T1/de not_active IP Right Cessation
- 1992-01-30 EP EP92101569A patent/EP0499098B1/en not_active Expired - Lifetime
- 1992-01-30 TW TW081100713A patent/TW205509B/zh active
- 1992-01-30 IE IE031192A patent/IE920311A1/en unknown
- 1992-01-30 FI FI924363A patent/FI924363A7/fi unknown
- 1992-01-30 SG SG1996004830A patent/SG45366A1/en unknown
- 1992-01-30 NZ NZ241463A patent/NZ241463A/xx unknown
- 1992-09-29 KR KR1019920702364A patent/KR100219965B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0499098A2 (en) | 1992-08-19 |
| IL100800A (en) | 1996-10-31 |
| IE920311A1 (en) | 1992-07-29 |
| SG45366A1 (en) | 1998-01-16 |
| ZA92663B (en) | 1993-07-30 |
| US5308606A (en) | 1994-05-03 |
| FI924363L (fi) | 1992-09-29 |
| EP0499098B1 (en) | 2002-04-17 |
| AU650944B2 (en) | 1994-07-07 |
| WO1992013571A1 (en) | 1992-08-20 |
| TW205509B (enExample) | 1993-05-11 |
| DE69232554T2 (de) | 2002-08-08 |
| FI924363A0 (fi) | 1992-09-29 |
| JPH05505629A (ja) | 1993-08-19 |
| AU1054392A (en) | 1992-08-06 |
| DE69232554D1 (de) | 2002-05-23 |
| KR100219965B1 (ko) | 1999-09-01 |
| CA2060332A1 (en) | 1992-07-31 |
| IL100800A0 (en) | 1992-09-06 |
| MX9200413A (es) | 1992-08-01 |
| FI924363A7 (fi) | 1992-09-29 |
| EP0499098A3 (en) | 1992-08-26 |
| ATE216266T1 (de) | 2002-05-15 |
| KR930700163A (ko) | 1993-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH31049A (en) | Bicyclopolyazamacrocy clophosphonic acid complexesfor use as radiopharmaceuticals. | |
| DE69635080T2 (de) | Radiometall-bindende analoge von lhrh | |
| CA2453845A1 (en) | Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy | |
| WO1997017446A3 (en) | HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF | |
| ZA989150B (en) | Mouth hygienic composition for the treatment of halitosis | |
| GR3035717T3 (en) | Tie-2 ligands, methods of making and uses thereof | |
| CA2115249A1 (en) | Phosphopeptides for the treatment of dental calculus | |
| NO20016427L (no) | Blandinger og fremgangsmåter for behandling av diagnose av lungekreft | |
| CA2264097A1 (en) | Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| AU4299496A (en) | Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods ofpreparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions | |
| CA2065299A1 (en) | Direct radiolabeling of antibodies and other proteins with technetium or rhenium | |
| EP0859637A4 (en) | COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF WEIGHT PROBLEMS, INCLUDING OBESITY | |
| UA32577C2 (uk) | Радіомічена сполука для утворення зображення тромбів при радіонуклідній діагностиці, радіофармацевтичний препарат та радіофармацевтична композиція на їх основі та комплект для приготування радіофармацевтичних препаратів | |
| CA2373794A1 (en) | Compositions and uses of et743 for treating cancer | |
| AU5314694A (en) | New agents for diagnosis of vascular diseases | |
| HUP0001084A3 (en) | Modified release oral pharmaceutical composition containing 5-asa for the treatment of bowel diseases | |
| SI1488806T1 (sl) | Blokirno monoklonsko protitelo proti vla-1 in njegova uporaba za zdravljenje žilnih obolenj | |
| CA2116829A1 (en) | Use of a pregnane derivative | |
| UA41984C2 (uk) | Спосіб інгібування утворення тромбів у людини (варіанти), спосіб лікування людини для зниження у людини небезпеки постхірургічних тромботичних ускладнень (варіанти),спосіб лікування тромботичного судинного захворювання у людини (варіанти), фармацевтична композиція, що містить некон'юговане антифібринове моноклональне антитіло мн-1, фармацевтична композиція, що містить некон'югований фрагмент або похідне антифібринового моноклонального антитіла мн-1, набір для лікування людини, що потребує інгібування утворення тромбу | |
| JPH11513374A (ja) | （放射性）標識化ビオチン誘導体類 | |
| CN121693350A (zh) | 药物偶联物及其制备与使用方法 | |
| PL328266A1 (en) | Therapeutic compounds | |
| IL146406A0 (en) | Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions | |
| Wolfrom et al. | Similar Outcome in Boys with Isolated and Combined Testicular Acute Lymphoblastic Leukemia Relapse After Stratified BFM Salvage Therapy | |
| WO1997047329A3 (en) | Radiopharmaceutical compositions capable of localizing at sites of thrombus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |